4-(Chloromethyl)Thiazole Hydrochloride

4-(Chloromethyl)Thiazole Hydrochloride


    • Product Name 4-(Chloromethyl)Thiazole Hydrochloride
    • Alias 4-(Chloromethyl)-1,3-thiazole hydrochloride
    • Einecs 68411-24-1
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    375270

    Chemical Formula C4H5Cl2NS
    Molecular Weight 170.06
    Appearance Solid

    As an accredited 4-(Chloromethyl)Thiazole Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of 4-(Chloromethyl)Thiazole Hydrochloride in a sealed, chemical - resistant bag.
    Shipping 4-(Chloromethyl)Thiazole Hydrochloride is shipped in sealed, corrosion - resistant containers. It adheres to strict chemical transport regulations, ensuring safe transit to prevent any leakage or damage during shipping.
    Storage 4-(Chloromethyl)thiazole hydrochloride should be stored in a cool, dry place, away from heat sources and direct sunlight. Keep it in a well - sealed container to prevent moisture absorption and contact with air, which could potentially lead to degradation. Store it separately from incompatible substances, such as oxidizing agents and bases, to avoid chemical reactions.
    Application of 4-(Chloromethyl)Thiazole Hydrochloride

    Pre-complexation of the free base form with palladium catalysts in degassed DMF permits a regioselective Suzuki coupling at the chloromethyl position, a pathway exploited in the construction of thiazole-bearing non-nucleoside reverse transcriptase inhibitors (NNRTIs). The hydrochloride salt is first neutralized with aqueous KHCO₃ under nitrogen at 0.9 mol·L⁻¹ concentration, extracted into MTBE, and dried over molecular sieves to yield the free amine analogue containing 4-(chloromethyl)thiazole. In a typical N-alkylation sequence targeting diarylmethyl-substituted thiazole intermediates, the free base is added dropwise to a suspension of the nucleophile, K₂CO₃ (3.0 equiv), and KI (0.1 equiv) in anhydrous CH₃CN at 65 °C. The molar ratio of 4-(chloromethyl)thiazole to the amine nucleophile is maintained at 1.15:1.00 to suppress dialkylation. After 8–12 hours, HPLC analysis (C18 column, 0.1% TFA in H₂O/MeCN gradient) indicates ≥97% conversion. Process-scale purification is executed by crystallization from isopropanol/water (3:1 v/v) with a yield window of 78–84%. Residual solvent analysis per USP〈467〉 and heavy metal testing per USP〈231〉 are mandatory; batches failing Pd content below 10 mg·kg⁻¹ are re-subjected to a SiliaMetS Thiol scavenger cartridge cascade. This intermediate proceeds to form the P2′ pharmacophore of investigational protease inhibitors evaluated in clinical isolates resistant to darunavir, with the thiazole ring engaging the S2 subsite through a conserved water-mediated hydrogen bond. The final drug substance synthesis is performed under ICH Q7 active pharmaceutical ingredient GMP, with process-related impurities controlled at ≤0.10% per individual unknown and ≤0.15% for the des-chloro des-methyl analog.

    What Enables the Thiazole Ring to Escalate SDHI Fungicide Potency Against Sclerotinia?

    Succinate dehydrogenase inhibitor (SDHI) fungicides incorporating a 2-methyl-4-(substituted)thiazole-5-carboxamide scaffold derive their binding affinity from the planarity and electron-withdrawing character of the thiazole core. 4-(Chloromethyl)thiazole hydrochloride serves as the critical C4-building block for the thiazole ring closure when condensed with substituted acetoacetates via a Hantzsch-type synthesis. A manufacturing route documented for thifluzamide analogs starts with the in situ generation of the free base from the hydrochloride in ethanol at 50 °C, using sodium ethoxide (1.02 equiv). To this solution, 2-chloro-4’-trifluoromethoxyacetoacetanilide is added along with ammonium acetate, followed by reflux for 6 hours. The reaction mass is then drowned into ice water; the precipitated thiazole intermediate is collected, washed, and recrystallized from toluene to 99.2% chemical purity (GC-FID). The chloromethyl group is subsequently oxidized to an aldehyde via a Kornblum reaction (DMSO, NaHCO₃, 120 °C) or directly converted to the carboxylic acid using HNO₃/H₂SO₄ at 0–5 °C. During the oxidation step, strict temperature control within a ±3 °C band prevents ring sulfoxidation, a side reaction that generates a genotoxic impurity classified under ICH M7 Class 3. The final coupling with 2,6-dibromo-4-trifluoromethoxyaniline via the acid chloride method (SOCl₂, catalytic DMF, CH₂Cl₂) delivers the active ingredient in 68–73% overall yield. Field trial data against Sclerotinia sclerotiorum in oilseed rape conducted per EPPO PP 1/78(4) show EC₅₀ values ≤0.12 mg·L⁻¹ when the chloromethyl oxidation sequence is optimized to avoid over-chlorinated byproducts; deviations above 0.5% dichloro impurity elevate the EC₅₀ to 0.55 mg·L⁻¹. REACH registration dossier requires an Ames test (OECD 471) negative for the purified intermediate and a 28-day repeated dose toxicity study (OECD 407) on the representative formulation before ton-scale approval.

    Aphid pressure in brassica and rice cultivation continues to drive demand for insecticidal chemotypes distinct from imidacloprid-resistance mutations. The 4-(chloromethyl)thiazole moiety is the cornerstone of 2-chloro-5-chloromethylthiazole-based neonicotinoids, wherein regioselective isomerization of the chloromethyl group from the 4- to the 5-position is catalyzed by tetrabutylammonium bromide in molten thiazole at 140 °C under a nitrogen sweep. The hydrochloride salt is first desalted with aqueous NaOH to an oil, dried, and then isomerized in the presence of 5 mol% TBAB; the equilibrium shifts to a 92:8 5-isomer:4-isomer ratio within 4 hours as monitored by 1H NMR (CDCl₃, δ 4.65 ppm vs. δ 4.72 ppm for CH₂Cl signals). The isomerized oil is directly chlorinated with Cl₂ gas in CCl₄ under actinic irradiation to install the 2-chloro substituent, yielding 2-chloro-5-chloromethylthiazole, the key chloromethyl building block for clothianidin and its analogs. In a multi-purpose GLR reactor, the subsequent nitrosation and aminolysis sequence uses nitroguanidine prepared via nitration of guanidine nitrate with H₂SO₄/HNO₃ at −5 °C. The coupling with 2-chloro-5-chloromethylthiazole is conducted in DMF at 25 °C with K₂CO₃ as acid scavenger; the exothermic alkylation is controlled by slow addition over 90 minutes, limiting the temperature rise to ΔT ≤ 7 °C. After aqueous work-up, clothianidin technical is crystallized from ethyl acetate to a melting point of 176–178 °C and a purity of 98.5% (HPLC area% at 254 nm). Whole-effluent toxicity evaluation under EU Biocidal Products Regulation (BPR) requires acute toxicity data on Daphnia magna (OECD 202) with 48-h EC₅₀ for the technical ≥100 mg·L⁻¹ to avoid Category 1 aquatic chronic classification. Formulation as water-dispersible granules (50% w/w active) using lignin sulfonate dispersant and kaolin carrier achieves a dust-free granule with a dispersion rate of ≥80% after 30 seconds in CIPAC standard water D.

    When 4-(Chloromethyl)Thiazole Salts Act as Visible-Light Photoinitiator Synthons

    Converting 4-(chloromethyl)thiazole hydrochloride to the corresponding 1,3-thiazolium iodochromate or to a bis-thiazolylmethane-type donor-acceptor chromophore opens a pathway to Type II photoinitiators for visible-light curing of acrylate-based coatings. The hydrochloride is first counterion-exchanged to the tetrafluoroborate or hexafluorophosphate salt by metathesis with NaBF₄ or KPF₆ in water at ambient temperature; the resulting 3-methyl-4-(chloromethyl)thiazolium salt is then quaternized with dimethylaminobenzaldehyde under microwave irradiation (CEM Discover, 100 W, 120 °C, 15 minutes) to produce a styrylthiazolium dye with λmax at 485 nm in acetonitrile, molar extinction coefficient ε = 4.2×10⁴ L·mol⁻¹·cm⁻¹. In a standard formulation for LED curing (405 nm source), the thiazolium dye is dissolved in trimethylolpropane triacrylate (TMPTA) at 0.5 wt% together with a co-initiator such as ethyl 4-(dimethylamino)benzoate (1.5 wt%) and a stabilizer (BHT, 0.1 wt%). Photocalorimetric analysis (photo-DSC, isothermal at 30 °C, light intensity 50 mW·cm⁻²) records a peak polymerization rate of 1.8×10⁻³ s⁻¹ and a final double bond conversion of 87% after 120 seconds exposure. The thiazole-based photoinitiator outperforms the camphorquinone/amine benchmark in the same matrix by reducing oxygen inhibition at the air-coating interface, a result attributed to the low triplet energy of the thiazole chromophore (52 kcal·mol⁻¹ calculated by DFT). On a pilot-scale LED curing line for wood flooring clear coats, the initiator formulation demonstrates complete surface cure at a line speed of 18 m·min⁻¹ with a single 395 nm LED array emitting 12 W·cm⁻². Byproduct formation during photolysis is monitored by GC-MS; the detected chloromethyl radical recombination products are below the 10 μg·m⁻³ threshold limit value-time weighted average set by German MAK Commission for the workplace atmosphere, provided extraction ventilation exchanges air at 30 m³·h⁻¹·m⁻².

    Introduction of a reactive chloromethyl handle onto a thiazole-europium(III) complex core produces a luminescent lanthanide probe that covalently grafts onto carboxylic acid-functionalized microtiter plate surfaces. The synthesis starts by condensing 4-(chloromethyl)thiazole-5-carbaldehyde (prepared by lithiation of the hydrochloride free base with n-BuLi at −78 °C in THF and subsequent DMF quench) with 2-hydrazinopyridine to form a tridentate N,N,O ligand. Reaction with EuCl₃·6H₂O in ethanol at 60 °C for 3 hours yields an orange-red emissive complex with a quantum yield Φ = 0.23 in phosphate-buffered saline (pH 7.4) when excited at 330 nm. The chloromethyl residue enables direct N-alkylation of poly(ethylene glycol) diamine spacer on a COOH-plasma-treated polystyrene 96-well plate; the coupling is carried out with K₂CO₃ in DMSO at 37 °C for 24 hours, resulting in a covalently tethered monolayer that withstands 20 wash cycles with Tris-buffered saline containing 0.05% Tween-20 without signal drift exceeding 5%. Time-resolved fluorescence resonance energy transfer (TR-FRET) detection of anti-cyclic citrullinated peptide antibodies in serum uses this coated plate coupled with a peptide epitope labeled with Alexa Fluor 680; the assay achieves a limit of detection of 0.4 U·mL⁻¹ and a dynamic range spanning 0.8–200 U·mL⁻¹. Validation according to CLSI EP17-A2 for clinical diagnostics requires a total coefficient of variation ≤8% across the measuring interval, a specification met only when residual free Eu³⁺ is removed by dialysis against EDTA (1 mM, 2 buffer exchanges) prior to immobilization.

    Comparative reactivity of 4-(chloromethyl)thiazole free base with nucleophiles under standard conditions
    NucleophileSolventTemperature (°C)Time (h)Conversion (%) a
    Phenoxide (K⁺ salt)DMF65596
    Thiophenoxide (Na⁺ salt)THF25299
    ImidazoleCH₃CN55888
    1,2,4-TriazoleDMSO701274
    PiperidineEtOH/H₂O (1:1)40398
    a Determined by GC-MS and expressed as area% of product; unreacted alkylating agent is not integrated.

    Conversion of 4-(chloromethyl)thiazole to the corresponding thiol via thiourea hydrolysis (thiourea, EtOH reflux, then NaOH) yields 4-mercaptomethylthiazole, a chelating agent for heavy metals in acidic wastewater streams. Treatment of spent electroless nickel plating baths (Ni²⁺ 800–1200 mg·L⁻¹, hypophosphite 25–40 g·L⁻¹) with a 10% (w/v) aqueous solution of the mercaptomethylthiazole sodium salt at a molar ratio of 2.2:1 (ligand:Ni) precipitates a brown nickel-thiazole complex at pH 4.5–5.0. Filtration through a plate-and-frame filter press equipped with polypropylene cloths (5 μm retention) reduces total nickel to ≤0.1 mg·L⁻¹, compliant with the EU Industrial Emissions Directive (2010/75/EU) BAT-AEL for surface treatment of metals. The loaded filter cake is amenable to sulfuric acid stripping at pH 1.0, recovering 93% of the thiol ligand for reuse; the nickel-rich strip solution is suitable for electrowinning.

    Free Quote

    Competitive 4-(Chloromethyl)Thiazole Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    The compound identified by CAS 7709-58-2, 4-(chloromethyl)thiazole hydrochloride, is furnished as a white to off-white crystalline solid with a molecular weight of 170.06 g·mol⁻¹. It serves as a key electrophilic intermediate in heterocyclic chemistry, predominantly for the installation of the 4-thiazolylmethyl moiety into nucleophilic substrates. The hydrochloride salt form provides a non-hygroscopic, free-flowing powder that is stable for 12 months when stored at −20 °C under argon. On a multi-kilogram scale, the material is typically double-bagged in antistatic LDPE liners, sealed inside fibre drums with desiccant packs to maintain water activity below 0.1.

    How Does the Hydrochloride Salt Form Influence Reactivity and Handling?

    Neutral 4-(chloromethyl)thiazole exists as a colourless to yellow liquid at ambient temperature, with a boiling point of approximately 70–72 °C at 2 mbar. The free base exhibits limited shelf life due to rapid discoloration and exothermic decomposition above 40 °C. Conversion to the hydrochloride salt raises the melting point to a range of 135–140 °C (decomposition) and transforms the physical form into a stable, crystalline powder. Differential scanning calorimetry (DSC) of a representative lot, heated at 10 K·min⁻¹ under nitrogen, shows a single endothermic event with an onset at 136.5 °C and a heat of fusion of 98 J·g⁻¹. In this protonated state, the thiazole nitrogen is deactivated toward oxidative side reactions; however, the chloromethyl group remains fully susceptible to nucleophilic substitution. Process development teams often pre-neutralise the salt with a stoichiometric amount of a hindered amine base—triethylamine or N,N-diisopropylethylamine—immediately prior to alkylation, liberating the free base in situ. Failure to control the exothermic neutralisation in large vessels (enthalpy measured at −45 kJ·mol⁻¹) has led to thermal runaways in uncooled 50 L glass-lined reactors. Therefore, a dosing-controlled semi-batch protocol is employed, maintaining the internal temperature at 0–5 °C during the addition of the base. Water content of the salt, determined by coulometric Karl Fischer titration per Ph. Eur. 2.5.12, must not exceed 0.5% (w/w); higher moisture levels promote hydrolysis of the chloromethyl group to 4-(hydroxymethyl)thiazole, a contaminant that is not separated by simple recrystallisation and lowers the effective assay.

    For use as an intermediate in active pharmaceutical ingredient (API) supply chains under GMP part II, the material is controlled against a panel of purity attributes. A typical certificate of analysis includes assay by reversed-phase HPLC on a C18 column (150 x 4.6 mm, 5 µm) with UV detection at 254 nm, mobile phase acetonitrile/0.1% phosphoric acid, delivering a retention time of approximately 8.2 minutes for the main peak. Acceptance criterion is set at ≥ 98.0 area%, though high-purity grades meeting ≥ 99.5% are achievable after activated carbon treatment and recrystallisation from isopropanol/methyl tert-butyl ether. The table below summarises the release specifications and test methodologies.

    ParameterSpecificationMethod
    AppearanceWhite to off-white crystalline powderVisual / Ph. Eur. 2.2.1
    Assay (HPLC)≥ 98.0% (anhydrous basis)Ph. Eur. 2.2.29
    Water (KF)≤ 0.5%Ph. Eur. 2.5.12
    Sulfated ash≤ 0.1%Ph. Eur. 2.4.14
    Heavy Metals≤ 10 ppmPh. Eur. 2.4.8 / USP <231>
    Related Substances (total)≤ 1.5%Ph. Eur. 2.2.29
    Residual Solvents (isopropanol)≤ 5000 ppmICH Q3C / Ph. Eur. 2.4.24
    Residual Solvents (MTBE)≤ 500 ppmICH Q3C / Ph. Eur. 2.4.24

    Comparative Alkylation Efficiency Against Bromomethyl and Iodomethyl Analogs

    In SN2-type displacement reactions with thiols, amines, or phenolate nucleophiles, the leaving-group identity dictates relative reaction rates and impurity profiles. The chloride in 4-(chloromethyl)thiazole hydrochloride exhibits a nucleofugality ranking that places it between the slower methanesulfonate and the substantially more labile bromide and iodide derivatives. Kinetic analysis under pseudo-first-order conditions with sodium azide in DMF at 25 °C gives a second-order rate constant, k2, of 2.4 × 10⁻³ M⁻¹·s⁻¹ for the chloride, versus 1.9 × 10⁻² M⁻¹·s⁻¹ for the analogous bromide and 1.1 × 10⁻¹ M⁻¹·s⁻¹ for the iodide (literature values interpolated from model halomethylthiazole substrates). This rate differential has direct consequences for exotherm control: the chloride variant permits safer scale-up due to slower heat release, while the bromide frequently generates impurity spikes because of competing elimination and polymerisation pathways at the higher local reaction temperatures that can develop in poorly stirred reactors. A comparative overview of commercially available halogenated thiazole building blocks is provided below.

    CompoundCAS RNPhysical FormMp / BpRelative Rate (Cl = 1.0)Notable Process Constraint
    4-(Chloromethyl)thiazole HCl7709-58-2White crystalline solid135–140 °C (dec.)1.0Hydrolysis at water > 0.5%; exotherm manageable via semi-batch dosing
    4-(Bromomethyl)thiazole HBr120155-58-2Pale yellow crystalline solid162–166 °C (dec.)8.0Runaway risk in batch mode; maximum batch size limited to 10 L without calorimetric data
    2-(Chloromethyl)thiazole HCl477254-56-3White to beige powder128–132 °C (dec.)1.2Regioselectivity in cephalosporin synthesis altered; yields lower by 10–15%

    When Anhydrous Conditions Are Not Maintained: Dealing with Hydrolysis By-Products

    Hydrolysis of the chloromethyl group is catalysed by both acid and base, with the pH-rate profile exhibiting a minimum at pH 4.5–5.0. At neutral pH and ambient temperature, the half-life of the dissolved compound in water is less than 6 hours, as monitored by HPLC peak area decay. Therefore, all manufacturing operations involving aqueous solutions are carried out at 0–5 °C, and solvent streams are pre-dried over molecular sieves type 3A to a water specification of ≤ 50 ppm. In a documented multi-batch campaign at pilot scale (50 kg input per batch), the primary impurity encountered was 4-(hydroxymethyl)thiazole, which accumulated up to 3.2% when a single drum of fresh solvent was inadvertently omitted from the sieves drying loop. The impurity could be purged only by recrystallisation from isopropanol/MTBE, resulting in a 12% yield loss. To prevent this, process analytical technology (PAT) using inline NIR spectroscopy has been deployed at the 100 L scale to track water content in real time; the trigger for aborting the campaign is set at an absorbance ratio at 1900 nm exceeding 0.15 absorbance units, corresponding to about 0.2% water in the reaction mixture. Powder X-ray diffraction (PXRD) of the dried product consistently shows a triclinic unit cell (a = 6.87 Å, b = 8.45 Å, c = 9.31 Å) with no detectable amorphous halo when the material is crystallised from the standard solvent system, confirming polymorphic purity that remains unchanged after jet-milling to a median particle size of 10 µm.

    In the established synthesis of the third-generation cephalosporin cefotaxime acid, 4-(chloromethyl)thiazole hydrochloride is employed to alkylate the thiol group of 2-mercaptobenzothiazole or to directly construct the (Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid side chain. A typical coupling protocol charges the hydrochloride salt into a pre-cooled (−10 °C) suspension of the oximino acid in anhydrous acetonitrile in the presence of 1.1 equivalents of triethylamine. The reaction mass is held at 0–5 °C for 4 hours before being quenched in 10% aqueous sodium bicarbonate. Reported isolated yields of the target thioether after acidification and ethyl acetate extraction are in the range of 82–89%, with the major by-product being the sulfoxide arising from over-oxidation if dissolved oxygen is not adequately stripped from the solvent via nitrogen sparging. The use of the 4-substituted isomer of chloromethylthiazole is critical here; the 2-substituted isomer, although commercially available, positions the thiazole nitrogen in a way that leads to a 7:3 mixture of regioisomeric products that cannot be easily separated, reducing the throughput of the downstream quality control step. Published regulatory starting material dossiers (Type II Drug Master File) for cefotaxime sodium reference the 4-(chloromethyl)thiazole hydrochloride as the preferred source of this fragment.

    Regulatory Starting Material Designation and Supply Chain Integrity

    The substance is classified under EU CLP Regulation (EC) No 1272/2008 as Skin Corr. 1B (H314), requiring engineering controls and personal protective equipment during handling. There are no halogenated dioxin or dibenzofuran formation risks under normal storage conditions, and TSE/BSE certificates are provided due to the fully synthetic origin. For supply across climatic zones II and IV, validated shipping configurations use expanded polystyrene containers with phase-change material packs rated at −10 °C, containing integrated USB data loggers that record temperature every 15 minutes. A deviation alert is triggered whenever the product temperature exceeds −5 °C for more than 2 contiguous hours. On receipt, the user is required to equilibrate the sealed drum to ambient temperature under nitrogen purge before opening, to avoid moisture condensation on the cold crystalline surface. Residual acetonitrile and triethylamine traces in the final product are controlled to ≤ 410 ppm and ≤ 320 ppm respectively, in accordance with the options for a Class 3 solvent per ICH Q3C. Concentrated solutions in dimethylacetamide stored at room temperature show 2.8% degradation by HPLC after 72 hours, so in-plant stock solutions are always prepared and used within a single shift.